Search Results - "Matl, Ivo"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Potential Predictive Markers in Protocol Biopsies for Premature Renal Graft Loss by Matl, Ivo, Hribova, Petra, Honsova, Eva, Brabcova, Irena, Viklicky, Ondrej

    Published in Kidney & blood pressure research (01-01-2010)
    “…Background/Aims: Protocol biopsies offer new possibilities to predict kidney allograft outcome. The aim of this study was to find clinical, laboratory,…”
    Get full text
    Journal Article
  2. 2

    RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation by Kalousová, Marta, Brabcová, Irena, Germanová, Anna, Jáchymová, Marie, Matl, Ivo, Mestek, Oto, Bandúr, Štěpán, Zima, Tomáš, Viklický, Ondřej

    Published in Clinical biochemistry (01-03-2009)
    “…RAGE (receptor for advanced glycation end products) is involved in pathogenesis of many diseases. The aim of the study was to test whether polymorphisms of…”
    Get full text
    Journal Article
  3. 3

    Kidney transplantation at the Institute for Clinical and Experimental Medicine by Viklický, Ondrej, Slatinská, Janka, Bürgelová, Marcela, Vítko, Stefan, Urbanová, Mariana, Lazanská, Renáta, Hanzal, Vladimír, Bandúr, Stepán, Teplan, Vladimír, Matl, Ivo, Janousek, Libor, Honsová, Eva, Drastichová, Monika, Malý, Jan

    Published in Časopis lékařů českých (2011)
    “…Kidney transplantation represents the method of choice of end stage renal disease. The program of kidney transplantation was established in 1966 in our centre…”
    Get more information
    Journal Article
  4. 4

    Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy by Viklický, Ondřej, Hubáček, Jaroslav A., Kvasnička, Jan, Matl, Ivo, Voska, Luděk, Skibová, Jelena, Teplan, Vladimı́r, Vı́tko, Štefan

    Published in Clinical biochemistry (01-10-2004)
    “…Objectives: The aim of this study was to evaluate the role of genetic polymorphisms on the development of chronic allograft nephropathy (CAN). Design and…”
    Get full text
    Journal Article
  5. 5

    The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients by Matl, Ivo, Viklický, Ondrej, Voska, Ludek, Lodererová, Alena, Vítko, Stefan

    Published in Transplant international (01-06-2005)
    “…Transforming growth factor (TGF)-beta1 is a key profibrogenic cytokine associated with the pathogenesis of chronic allograft nephropathy (CAN). The primary aim…”
    Get more information
    Journal Article
  6. 6

    Withdrawal of steroids from triple‐drug therapy in kidney transplant patients by Matl, Ivo, Lácha, Jiří, Lodererová, Alena, Šímová, Marcela, Teplan, Vladimír, Lánská, Věra, Vítko, Štefan

    Published in Nephrology, dialysis, transplantation (01-07-2000)
    “…Background. In renal transplant patients with stable graft function, triple‐drug immunosuppression may not be necessary, while withdrawal of steroids may…”
    Get full text
    Journal Article
  7. 7